![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 17, 2004 2:02:39 PM
Dr. Lamine Ba, Ambassador of Senegal, who recently learned about NeedleZap® and has already endorsed the product to the Senegalese Ministry of Health, was integral in the organization of the meeting. According to the most recent report from the United Nations, an estimated 25 million people are infected with HIV in Sub-Saharan Africa. Senegal, in contrast, has done well in its fight to limit the spread of HIV/AIDS. The country has an infection rate of approximately 2 percent, one of the lowest on the African continent. For that reason, Dr. Ba felt strongly that other members of the African diplomatic community should learn about NeedleZap®.
"To be effective against curtailing the spread of HIV/AIDS, you have to look at all the root causes," said Dr. Ba, E Med's Guest of Honor at the event. "The re-use of contaminated needles is just one of many problems African countries have to combat if progress is to be made against this deadly disease. That's why it's important to hold this forum where the benefits of NeedleZap® can be explained and demonstrated."
R.J.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM